TAILIN (300813.SZ): Plans to postpone the "Cell Therapy Industrialization Equipment Manufacturing Base Project" until June 30, 2025.

Gelonghui, December 31丨TAILIN (300813.SZ) announced that the company will hold the fifth meeting of the fourth Board of Directors and the fifth meeting of the fourth Supervisory Board on December 31, 2024. The proposal concerning the extension of the fundraising for the issuance of Convertible Bonds to unspecified entities was reviewed and approved. Under the condition that the investment project主体, implementation location, investment purpose, and investment scale do not change, based on the current actual construction progress of the fundraising investment project, the fundraising for the Convertible Bonds will be allocated to the "Cell Therapy Industrialization Equipment Manufacturing Base Project" to reach the predetermined usable state.

Gelonghui FinanceDec 31, 2024 16:10

Tailin (300813.SZ): has obtained multiple patent certificates and computer software copyright registration certificates.

Gelonghui December 2nd | Tailin (300813.SZ) announced that its wholly-owned subsidiaries Zhejiang Tailin Life Science Co., Ltd. (hereinafter referred to as "Tailin Life Science"), Zhejiang Tailin Medical Engineering Co., Ltd. (hereinafter referred to as "Tailin Medical Engineering"), Zhejiang Tailin Analytical Instrument Co., Ltd. (hereinafter referred to as "Tailin Analytical Instrument"), and Zhejiang Tailin Medical Instruments Co., Ltd. (hereinafter referred to as "Tailin Medical Instruments") have recently obtained a total of 6 patent certificates and 3 computer software copyright registration certificates. The patent certificates include methods for controlling VHP vaporization equipment and sterilization equipment; computer software.

Gelonghui FinanceDec 2, 2024 15:48

Tailin Biotech: Report for the third quarter of 2024

SZSIOct 30, 2024 00:00 · Announcements

Express News | Tailin: Wholly-owned subsidiary obtains 8 patent certificates.

BreakingsSep 10, 2024 15:46

A-share immunotherapy concept soared, guanhao biotech rose 20% to daily limit.

September 2nd, Guanhao Biotech rose by 20% to its daily limit, Tailin rose by over 13%, Landfar Bio-Medicine and Vcanbio Cell & Gene Engineering Corp.,Ltd. also hit the limit up, Canature Health Technology and others rose significantly. On the news front, The Third Tianfu Stem Cell and Cell Therapy Conference will be held from September 6th to 8th.

Gelonghui FinanceSep 2, 2024 10:03

Tailin Biotech: 2024 Semi-Annual Report Summary

SZSIAug 29, 2024 00:00 · Announcements